Compare J.B.Chemicals with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs PANACEA BIOTECH - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS PANACEA BIOTECH J.B.CHEMICALS/
PANACEA BIOTECH
 
P/E (TTM) x 39.0 12.0 324.3% View Chart
P/BV x 7.3 4.7 154.8% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 J.B.CHEMICALS   PANACEA BIOTECH
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
PANACEA BIOTECH
Mar-19
J.B.CHEMICALS/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs363354 102.7%   
Low Rs255138 184.5%   
Sales per share (Unadj.) Rs169.174.6 226.8%  
Earnings per share (Unadj.) Rs16.66.7 248.5%  
Cash flow per share (Unadj.) Rs23.415.5 151.1%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs172.557.2 301.5%  
Shares outstanding (eoy) m83.5761.25 136.4%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.83.3 55.4%   
Avg P/E ratio x18.636.8 50.6%  
P/CF ratio (eoy) x13.215.9 83.2%  
Price / Book Value ratio x1.84.3 41.7%  
Dividend payout %12.00-   
Avg Mkt Cap Rs m25,82715,061 171.5%   
No. of employees `0003.82.3 163.0%   
Total wages/salary Rs m2,5111,471 170.7%   
Avg. sales/employee Rs Th3,747.41,973.6 189.9%   
Avg. wages/employee Rs Th665.7635.6 104.7%   
Avg. net profit/employee Rs Th367.8176.8 208.0%   
INCOME DATA
Net Sales Rs m14,1354,567 309.5%  
Other income Rs m36645 816.5%   
Total revenues Rs m14,5014,612 314.4%   
Gross profit Rs m2,1782,030 107.3%  
Depreciation Rs m570540 105.5%   
Interest Rs m351,048 3.3%   
Profit before tax Rs m1,940486 398.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m55277 716.3%   
Profit after tax Rs m1,387409 339.1%  
Gross profit margin %15.444.4 34.7%  
Effective tax rate %28.515.9 179.6%   
Net profit margin %9.89.0 109.6%  
BALANCE SHEET DATA
Current assets Rs m10,4702,415 433.6%   
Current liabilities Rs m2,7499,077 30.3%   
Net working cap to sales %54.6-145.9 -37.4%  
Current ratio x3.80.3 1,431.9%  
Inventory Days Days5565 84.8%  
Debtors Days Days7871 109.5%  
Net fixed assets Rs m5,8118,333 69.7%   
Share capital Rs m16761 272.6%   
"Free" reserves Rs m14,2483,443 413.9%   
Net worth Rs m14,4163,504 411.4%   
Long term debt Rs m0461 0.0%   
Total assets Rs m17,64913,755 128.3%  
Interest coverage x56.61.5 3,864.8%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.80.3 241.2%   
Return on assets %8.110.6 76.1%  
Return on equity %9.611.7 82.4%  
Return on capital %13.738.7 35.4%  
Exports to sales %020.9 0.0%   
Imports to sales %08.1 0.0%   
Exports (fob) Rs mNA954 0.0%   
Imports (cif) Rs mNA372 0.0%   
Fx inflow Rs m6,1641,203 512.4%   
Fx outflow Rs m1,334467 286.0%   
Net fx Rs m4,829736 655.8%   
CASH FLOW
From Operations Rs m1,2311,049 117.3%  
From Investments Rs m-208-54 389.0%  
From Financial Activity Rs m-595-1,011 58.8%  
Net Cashflow Rs m427-20 -2,168.0%  

Share Holding

Indian Promoters % 55.4 74.5 74.4%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 0.6 565.0%  
FIIs % 3.9 1.3 300.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 23.6 156.8%  
Shareholders   30,437 10,259 296.7%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   GSK PHARMA  ASTRAZENECA PHARMA  DIVIS LABORATORIES  IPCA LABS  JUBILANT PHARMOVA   

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Zooms 661 Points, Nifty Ends Above 14,500; M&M and Bajaj Finserv Top Gainers(Closing)

Indian share markets witnessed most of the buying interest during closing hours today and ended on a strong note.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

If the Market Falls, I Will Do This...(Fast Profits Daily)

Apr 1, 2021

What should you do if the market falls? In this video, I'll tell you what I will do.

The Indian Real Estate Party Has Just Begun(Profit Hunter)

Apr 1, 2021

A favourable demand supply scenario makes a strong case for real estate prices.

The Dilemma of Investing in Bharti Airtel(Views On News)

Apr 1, 2021

Rahul Shah on whether Bharti Airtel will emerge as the next big thing in the Indian stock market

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Apr 13, 2021 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - ALEMBIC COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS